Copyright
©The Author(s) 2025.
World J Gastroenterol. May 21, 2025; 31(19): 104563
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.104563
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.104563
Table 1 Baseline characteristics of Budd-Chiari syndrome patients with gastroesophageal varices stratified by variceal bleeding status
| Variables | Bleeding group (n = 61) | Non-bleeding group (n = 383) | P value |
| Age (years) | 52.1 ± 11.2 | 51.4 ± 10.8 | 0.640 |
| Sex (male) | 50 (82) | 209 (54.6) | < 0.001 |
| Diabetes | 3 (4.9) | 29 (7.6) | 0.633 |
| Ascites | 33 (54.1) | 144 (37.6) | 0.015 |
| Hepatic encephalopathy | 2 (3.3) | 11(2.9) | 1.000 |
| IVC or HV thrombosis | 9 (14.8) | 79 (20.6) | 0.285 |
| Portal vein thrombosis | 7 (11.5) | 16 (4.2) | 0.038 |
| Spleen thickness (mm) | 46 (39, 58) | 45 (39, 49) | 0.041 |
| Portal vein diameter (mm) | 12.7 (10.0, 14.5) | 12.7 (10.0, 15.0) | 0.994 |
| BCS type | 0.042 | ||
| HV type | 19 (31.1) | 67 (17.5) | |
| Mixed type | 35 (57.4) | 269 (70.2) | |
| IVC type | 7 (11.5) | 47 (12.3) | |
| Child-Pugh grade | < 0.001 | ||
| A | 26 (42.6) | 256 (66.8) | |
| B | 21 (34.4) | 121 (31.6) | |
| C | 14 (23) | 6 (1.6) | |
| ALBI, median (IQR) | -2.07 (-2.57, -1.28) | -2.38 (-2.75, -1.97) | < 0.001 |
| MELD, median (IQR) | 8.22 (4.07, 13.00) | 4.15 (1.72, 7.19) | < 0.001 |
| Use of anticoagulant medication | 56 (91.8) | 310 (80.9) | 0.038 |
| Invasive treatment to relieve hepatic venous outflow obstruction | 27 (44.3) | 344 (89.8) | < 0.001 |
| White blood cell (× 109/L) | 3.8 (2.9, 5.0) | 3.4 (2.7, 4.5) | 0.271 |
| Red blood cell (× 1012/L) | 3.7 (2.8, 4.4) | 4.0 (3.6, 4.4) | 0.016 |
| Hemoglobin (g/L) | 115 (77.5, 134.0) | 124 (109, 138) | 0.005 |
| Platelet (× 109/L) | 71 (48.5, 98) | 90 (67, 126) | < 0.001 |
| Sodium (mmol/L) | 140 (137.5, 142.0) | 142 (140, 143.9) | < 0.001 |
| Creatinine (µmol/L) | 62 (48.5, 76.5) | 55 (46, 65) | 0.007 |
| Alanine aminotransferase (U/L) | 23 (19, 39.5) | 21 (17, 27) | 0.019 |
| Aspartate aminotransferase (U/L) | 32 (23.5, 50) | 27 (23, 34) | 0.001 |
| Gamma-glutamyl transferase (U/L) | 74 (41, 151) | 60.6 (36.5, 111) | 0.065 |
| Alkaline phosphatase (U/L) | 106 (80.6, 142) | 90 (72, 117) | 0.006 |
| Total protein (g/L) | 61.1 (54.1, 66.9) | 63.2 (58.7, 67.8) | 0.018 |
| Albumin (g/L) | 33.2 (28.7, 39.8) | 38.3 (34, 42) | < 0.001 |
| Total bilirubin (µmol/L) | 26.5 (14.8, 60.2) | 21 (14.1, 31.5) | 0.015 |
| Prothrombin time (s) | 16.3 (14.7, 18.5) | 14.6 (13.7, 16.0) | < 0.001 |
- Citation: Wang ZD, Nan HJ, Li SX, Li LH, Liu ZC, Guo HH, Li L, Liu SY, Li H, Bai YL, Dang XW. Development and validation of a radiomics-based prediction model for variceal bleeding in patients with Budd-Chiari syndrome-related gastroesophageal varices. World J Gastroenterol 2025; 31(19): 104563
- URL: https://www.wjgnet.com/1007-9327/full/v31/i19/104563.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i19.104563